Andere Sprachen Senseonics Holdings, Inc.

Aktien

A2AGQW

US81727U1051

SENS

Markt geschlossen - Nyse Andere Börsenplätze 22:00:00 03.05.2024			% 5 Tage	% 1. Jan.
0,5049 ^USD	-2,55 %		+21,46 %	-11,44 %

30.04.	Senseonics Holdings, Inc. gibt bekannt, dass das Eversense CGM-System von der U.S. Food and Drug Administration die iCGM-Zertifizierung erhalten hat	CI
25.03.	Senseonics Holdings, Inc. kündigt Änderungen im Vorstand an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Senseonics Holdings, Inc. to Participate in Upcoming Conferences	02.05.
Senseonics Holdings, Inc. - Eversense CGM System Receives iCGM Designation by the US FDA	01.05.
Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time	30.04.
Eversense® CGM System Receives iCGM Designation by the US FDA	30.04.
Senseonics Holdings, Inc. Announces Eversense CGM System Receives iCGM Designation by the U.S. Food and Drug Administration	30.04.
Senseonics Holdings, Inc. Announces Board Changes	25.03.
Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes	08.03.
Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference	06.03.
Senseonics: Q4 Earnings Snapshot	29.02.
Senseonics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29.02.
Senseonics Holdings, Inc. Provides Revenue Guidance for the First Half of 2024	29.02.
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results	29.02.
Earnings Flash (SENS) SENSEONICS HOLDINGS Posts Q4 Revenue $8M, vs. Street Est of $7.6M	29.02.
Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern Time	15.02.
Senseonics - Medicare Coverage Significantly Expanded for the Eversense E3 CGM System	13.02.
Medicare Coverage Significantly Expanded for the Eversense E3 CGM System	12.02.
PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care, Newly Created Leadership Role Reinforces PHC Group Commitment to Diabetes Innovation	07.02.
Ascensia appoints Brian Hansen as CGM Business Manager, Strengthening PHC Group's presence in the continuous blood glucose monitoring market	07.02.
PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care	06.02.
Senseonics Q4 Revenue Guidance Tops Consensus	02.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Senseonics Holdings, Inc.

Aktien

A2AGQW

US81727U1051

SENS

Andere Sprachen

Filter